Epidemiological studies have evaluated the association between X-ray repair cross-complementing group 1 gene (XRCC1) Arg399Gln and Arg194Trp polymorphisms and risk of prostate cancer (PCa). However, the results from the published studies on the association between these two XRCC1 polymorphisms and PCa risk are conflicting. To derive a more precise estimation of association between the XRCC1 polymorphisms and risk of PCa, we performed a meta-analysis. A comprehensive search was conducted to identify all case-control studies of XRCC1 polymorphisms and PCa risk. We used odds ratios (ORs) with 95% confidence intervals (CIs) to assess the strength of the association. Overall, we found that both Arg399Gln and Arg194Trp polymorphisms were not significantly associated with PCa risk. However, in stratified analysis by ethnicity, we found that the Arg399Gln polymorphism was significantly associated with PCa risk in Asian population (Gln/Gln vs Arg/Arg: OR ¼ 1.46, 95% CI: 1.05-2.03, P ¼ 0.03; Gln/Gln vs Arg/ Gln þ Arg/Arg: OR ¼ 1.48, 95% CI: 1.12-1.95, P ¼ 0.01). In this meta-analysis, we found that both Arg399Gln and Arg194Trp polymorphisms were not related to overall PCa risk. However, in subgroup analysis we found a suggestion that XRCC1 399Gln allele might be a low-penetrent risk factor for PCa only in Asian men.
Introduction
Prostate cancer (PCa) is one of the most common malignancies of males in western countries. 1 The etiology of PCa is poorly understood, with genetic predisposition and environmental factors likely contributing to the risk. 2 The most recognized factors associated with PCa risk are ethnicity, age, and family history of the disease. Besides, studies have reported that both endogenous/exogenous hormonal substances and some gene polymorphisms could be potential risk factors of PCa. [3] [4] [5] Recent studies suggest that genetic polymorphisms of genes involved in DNA repair, including the X-ray repair cross-complementing group 1 gene (XRCC1), might affect susceptibility to PCa. [6] [7] [8] XRCC1 gene, located on chromosome 19q13.2-13.3, is involved in the repair of DNA base damage and singlestrand DNA breaks by binding DNA ligase III at its carboxyl and by binding DNA polymerase and poly (adenosine diphosphate ribose) polymerase at the site of damaged DNA. 9 Deletion of the XRCC1 in mice results in an embryonic lethal phenotype. 10 Chinese hamster ovary cell lines with mutations in the XRCC1 have shown a reduced ability to repair single strand breaks in DNA and concomitant cellular hypersensitivity to ionizing radiation and alkylating agents.
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XRCC1 has an essential role in removing endogenous and exogenous DNA damage. Arg399Gln (exon 10, base 28152 G to A, arginine to glutamine) and Arg194Trp (exon 6, base 26304 C to T, arginine to tryptophane) are two common polymorphisms of XRCC1. These two polymorphisms, involving an amino acid change at evolutionarily conserved regions, could alter the XRCC1 function. The XRCC1 Arg399Gln variant is located at the COOH-terminal side of the poly (adenosine diphosphate ribose) polymerase-interacting domain within a relatively non-conserved region between conserved residues of the BRCT (first described at the carboxyl terminus of the breast cancer protein breast cancer 1) domain, which is indicated as a protein-protein interaction module in many proteins involved in DNA repair. 12 In addition, the variant may be related with several phenotypic alterations, including higher levels of sister chromatid exchange, 13 aflatoxin B1-DNA adducts, glycophorin A mutations 14 and polyphenol DNA adducts. 15 The Arg194Trp polymorphism, which occurs in nuclear antigen-binding region of the proliferating cell, is suggested to enhance individual DNA repair capability. 16 So far, many studies have focused on the associations between PCa risk and DNA repair pathway gene polymorphisms. However, the results of these studies [6] [7] [8] [17] [18] [19] [20] [21] [22] [23] [24] [25] are conflicting and inconclusive. Therefore, it is highly necessary to perform a quantitative and systematic study with rigorous methods. In the present study, a meta-analysis was performed from all eligible studies to address the association between XRCC1 polymorphisms (Arg399Gln and Arg194Trp) and PCa risk.
Materials and methods

Publication search
PubMed and EMBASE were searched (the last search was updated in March 2011) using the search terms: 'XRCC1 or X-ray repair cross-complementing group 1', 'polymorphism', and 'prostate cancer or prostate neoplasm'. All published papers in English language with available full text matching the eligible criteria were retrieved. In addition, we also checked the references of relevant reviews and eligible articles that our search retrieved. Two investigators searched the literature and extracted data independently.
Inclusion, exclusion criteria and data abstraction
For inclusion in this meta-analysis, the identified articles had to provide information on the following: (1) evaluation of XRCC1 Arg399Gln and/or Arg194Trp polymorphisms and PCa risk, (2) using a case-control design and (3) sufficient data for examining an odds ratio (OR) with 95% confidence interval (CI); (4) the most recent and/or the largest study with extractable data should be included concerning studies with overlapping patients and the controls. Major reasons for the exclusion of studies were as follows: (1) no control cases; (2) no usable data reported; (3) duplicates. For each of the eligible case-control studies, the following data were collected: first author, publishing year, ethnicity of subjects, source of controls, numbers of genotyped cases and controls, genotyping methods. Different ethnic descents were categorized as Caucasian, Asian and African. For studies 21, 23 including different ethnic populations, the data were collected separately whenever possible and served as independent studies. Because one study 25 presented the data for genotypes as 'Arg/Arg, Arg/ Gln þ Gln/Gln' without data for all three genotypes, we can only calculate the OR for the dominant model.
Statistical analysis
The strength of the association between the XRCC1 Arg399Gln and Arg194Trp polymorphisms and PCa risk was measured by ORs with 95% CIs. For XRCC1 Arg399Gln polymorphism, we first examined the risk of the variant genotypes Gln/Gln or Gln/Arg on PCa compared with the wild-type Arg/Arg homozygote. Then, the risk of (Gln/Gln þ Gln/Arg) vs Arg/Arg and Gln/Gln vs (Gln/Arg þ Arg/Arg) for PCa was evaluated in dominant and recessive models. For XRCC1 Arg194Trp polymorphism, we evaluated the same effects. Stratified and meta-regression analyses were performed by ethnicities.
Heterogeneity assumption was checked by a w 2 -based Q-test. 26 A P-value of more than 0.05 for the Q-test indicated a lack of heterogeneity among the studies, so the summary OR estimate of each study was calculated by the fixed-effects model (the Mantel-Haenszel method). Otherwise, the random effects model (DerSimonian and Laird method) was used. 27, 28 The significance of the pooled OR was determined by the Z-test and Po0.05 was considered as statistically significant. To evaluate the covariate effects, subgroup and meta-regression analyses were conducted based on different ethnicities. Monte Carlo permutation test was performed (iterations ¼ 20 000) to adjust the P-value for multiple comparisons based on the work by Higgins et al. 29 Knapp and Hartung adjustment was also used to control the type I error rate. 30 To investigate whether publication bias might affect the validity of the estimates, funnel plot was constructed. An asymmetric plot suggests a possible publication bias. Funnel plot asymmetry was assessed by the method of Egger's linear regression test, a linear regression approach to measure funnel plot asymmetry on the natural logarithm scale of OR. The significance of the intercept was determined by the t-test suggested by Egger (Po0.05 was considered representative of statistically significant publication bias). Hardy-Weinberg equilibrium in the control group was tested using the Pearson's w 2 -test for goodness of fit; Po0.05 was considered significant.
All statistical analyses were performed with the Stata software (version 9.0; StataCorp LP, College Station, TX, USA) using two-sided P-values.
Results
Eligible studies
Fourteen studies were included based on the search criteria for PCa susceptibility related to the XRCC1 Arg399Gln and Arg194Trp polymorphisms. Study characteristics were summarized in Supplementary Table 1 . There were five studies of subjects of Asian descent, seven studies of subjects of Caucasian descent and two studies of subjects of African descent. Among these studies, seven studies have investigated only Arg399Gln polymorphism, whereas seven studies included Arg399Gln and Arg194Trp polymorphisms. Therefore, there were 14 studies with 3782 cases and 3775 controls concerning the Arg399Gln polymorphism, and seven studies with 2153 cases and 2219 controls concerning the Arg194Trp polymorphism.
All the studies used frequency-matched controls to the cases by age, sex or ethnicity. A classical PCR-restriction fragment length polymorphism assay was conducted in nine studies. The amplification refractory mutation system, Applied Biosystems (ABI, Foster City, CA, USA) SNPlex (ABS) Genotyping system, matrix-assisted laser desorption ionization time of flight mass spectrometry and homogeneous MassExtend (HM) multiplex assays were used in the remaining five studies. The genotype distributions among the controls of all studies followed HardyWeinberg equilibrium except for one study 23 in African population for the Arg194Trp polymorphism.
Meta-analysis
In the overall Arg399Gln analysis, the Gln/Gln and Arg/ Gln genotypes were not significantly associated with Figure 1 ). This similar positive association was maintained in recessive model (Gln/Gln vs Arg/Gln þ Arg/Arg: OR ¼ 1.48, 95% CI: 1.12-1.95, P ¼ 0.01; Table 1, Figure 1 ). However, in the stratified analysis for Arg194Trp polymorphism, we did not find any positive relationship between the Arg194Trp polymorphism and PCa risk (date were shown in Supplementary Table 2, Figure 2 ). After P-value correction for multiple testing, there remains some weak evidences that the association was positive considering as extreme or more extreme as the observed condition (Gln/Gln vs Arg/Arg: corrected P ¼ 0.060; Gln/Gln vs Arg/Gln þ Arg/Arg, corrected P ¼ 0.066). 31 As well as multiple testing, we have also applied Knapp and Hartung adjustment to explore the association. The results further confirm the conclusion that genetic variable Arg399Gln associated with PCa risk in Asian population (Gln/Gln vs Arg/Arg: P ¼ 0.046; Gln/ Gln vs Arg/Gln þ Arg/Arg, P ¼ 0.040).
Test of heterogeneity
For Arg399Gln polymorphism, the heterogeneity was reckoned between each of the studies using the Q-test:
homozygote 
Sensitivity analysis
In the sensitivity analysis, the influence of each study on the pooled OR was examined by repeating the metaanalysis while omitting each study, one at a time. This procedure confirmed the stability of our overall result. In addition, when excluding one study 23 in African population for the Arg194Trp polymorphism that did not follow Hardy-Weinberg equilibrium, the estimated pooled OR still did not significantly change at all (data not shown).
Publication bias
Begg's funnel plot and Egger's test were conducted to assess the publication bias of the literature. The shape of funnel plots did not reveal any evidence of funnel plot asymmetry. The statistical results still did not show publication bias (for Arg399Gln polymorphism: P ¼ 0.13 for Gln/Gln vs Arg/Arg, P ¼ 0.72 for Gln/Arg vs Arg/ Arg, P ¼ 0.75 for dominant model and P ¼ 0.09 for recessive model; for Arg194Trp polymorphism: P ¼ 0.22 for Trp/Trp vs Arg/Arg, P ¼ 0.60 for Trp/Arg vs Arg/ Arg, P ¼ 0.69 for dominant model and P ¼ 0.20 for recessive model).
Discussion
We conducted a systematic search of the literatures and combined the available results in this meta-analysis, which is a useful strategy for elucidating genetic factors in cancer. [32] [33] [34] XRCC1, which is involved in the DNA repair, has been studied extensively about the relationship with different cancers, such as urothelial bladder cancer, 35 breast cancer, 36 PCa 25,37 and so on. Previous results of the studies on the relationship between XRCC1 polymorphisms and PCa risk were contradictory. These inconsistent results are possibly because of a small effect of the polymorphism on PCa risk or the relatively low statistical power of the published studies. Hence, the meta-analysis was needed to provide a quantitative approach for combining the results of various studies with the same topic, and for estimating and explaining their diversity.
The present meta-analysis, including 3782 cases and 3775 controls concerning the Arg399Gln polymorphism and 2153 cases and 2219 controls concerning the Arg194Trp polymorphism, explored the association between two potentially functional polymorphisms in 
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To reduce the type 1 error resulted by several covariates, we performed permutation method for multiple testing rather than Bonferroni method considering its limitations. 38 We could still detect the low-penetrant risk in Asian population even after stimulation for 20 000 times as extreme or more extreme condition. 31 This could be interpreted as describing the degree of 'surprise' one might have about the observed result for Asian population, considering all the covariates are being examined. 29 Moreover, permutation method sometimes resulted in tests with very low power. 39, 40 Therefore, we have also performed Knapp and Hartung adjustment (supported by Higgins et al. 29 as well) to correct P-value. Knapp and Hartung method could effectively decrease the false-positive rates in meta-regression and adjust the coverage probability of the CIs to be much closer to reality. It is based on t distribution in place of the standard normal distribution when calculating P-values and CIs. Even though the Knapp and Hartung modification will usually lead to more conservative P-values, 41 our modified results (Po0.05) credibly support the genetic variant association available in Asian population. It is consistent with the evidence from multiple testing or stratified analysis.
It was suggested that the XRCC1 Arg399Gln polymorphism was also associated with other cancers in Asian population, which included colorectal cancer, 42 lung cancer, 43 basal cell carcinoma 44 and so on. The study by Wang et al. 42 indicated that the XRCC1 399Gln allele was associated with a significantly increased rectal cancer risk among men. Besides, XRCC1 Arg399Gln polymorphism may alter the risk of lung cancer in women nonsmokers in China. 43 Kang et al. 44 found that the XRCC1 Arg399Gln polymorphism was associated with an increased risk of basal cell carcinoma. 44 Given the important roles of XRCC1 gene, it is biologically plausible that XRCC1 polymorphism may modulate the risk of PCa. The XRCC1 Arg399Gln polymorphism was shown to be correlated with DNA repair activity and associated with susceptibility to various cancers, including PCa. 18, 21 The presence of the Gln/Gln genotype of XRCC1 has been shown to be associated with tumor-suppressor gene TP53 mutations, 45 elevated levels of sister chromatid exchanges 15 and higher level of DNA adducts. 14 Thus, it may alter PCa susceptibility, especially in Asian population.
We found that the variant genotype of the XRCC1 Arg399Gln polymorphism, in Caucasian population, was not associated with significant increase in PCa risk. This result was consistent with previous studies. 17, 19, 24 Although the XRCC1 Arg194Trp polymorphism may be associated with DNA repair activity, no significant association of the variant genotype with PCa risk was found in Caucasian and Asian populations, suggesting the influence of the genetic variant may be masked by the presence of other as-yet unidentified causal genes involved in PCa. Besides, a possible role of ethnic differences in genetic backgrounds and the environment they lived in may affect this result. Other factors such as selection bias, different matching criteria may also have a role.
The DNA repair gene XRCC1 codes for a scaffolding protein physically associated with DNA polymerase b, DNA ligase III, human AP endonuclease, polynucleotide kinase and poly (adenosine diphosphate ribose) polymerase, which functions in a complex to facilitate base excision repair and single-strand break-repair processes. The base excision repair pathway mainly removes non-bulky base adducts produced by methylation, oxidation or reduction by ionizing radiation or oxidative damage. Several studies [46] [47] [48] suggested a possible interaction between XRCC1 polymorphisms and environmental factors on cancer risk. The gene-environment interactions have been of great interest to evaluate the exact roles of genetic polymorphisms. However, lacking of the original data of these studies limited our further evaluation of potential gene-environment interactions.
Some limitations of this meta-analysis should be addressed. First, lacking of the original data limited our further evaluation of potential interactions because the interactions among gene-gene, gene-environment, and even different polymorphic loci of the same gene may modulate PCa risk. Second, our result was based on unadjusted estimates, although a more precise analysis should be conducted if more detailed data were available, which would allow for an adjusted estimate by other factors such as age, smoking and alcohol. Lacking of the information for the data analysis may cause serious confounding bias. Third, there was not enough data on African population in this meta-analysis, especially for Arg194Trp polymorphism.
In summary, this meta-analysis provided evidence of the association between the XRCC1 Arg399Gln and Arg194Trp polymorphisms and PCa risk, supporting the hypothesis that both Arg399Gln and Arg194Trp polymorphisms were not related to overall PCa risk. In subgroup analysis, the significant association of XRCC1 399Gln allele with PCa risk was found only in Asian men. However, more sophisticated gene-gene and geneenvironment interactions should also be considered in future analysis, which should lead to better, comprehensive understanding of the association between the XRCC1 polymorphisms and PCa risk.
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